Default company panoramic image

Bio2 Technologies

Bio2 is bringing advanced biomaterials to the musculoskeletal surgery market enabling superior outcomes at reduced cost.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Woburn, MA, USA
  • Currency USD
  • Founded August 2009
  • Employees 6
  • Website

Company Summary

Bio2 Technologies, Inc. is a medical device company applying a proprietary fiber bonding process to create advanced resorbable materials for broad application in the $50B musculoskeletal market. The company's devices provide high compressive strength and feature a porous structure similar to bone. Bio2 is initially targeting the extremities and spine product categories replacing cadaver bone and plastics in bone grafting and fusion applications.


  • Default avatar
    Paul Nichols
    Chairman, President & CEO

    Mr. Nichols has 32 years experience with rapidly growing companies in the medical device industry, with the past 24 as an executive and entrepreneur in the musculoskeletal sector. Between 1995 and 2005 he was a founder and CEO of three orthopedic surgery technology companies with successful exits, the most recent being Nexa Orthopedics which was acquired by Tornier (NASD:TRNX) in 2007. Mr. Nichols has a BA in Mathematics from UC San Diego.

  • Default avatar
    Janet Krevolin, PhD
    Chief Technology Officer

    Ms. Krevolin has over 20 years experience in research and product development in the orthopedic surgery industry. Prior to joining Bio2 she held the position of Vice President, Global Product Development for Zimmer Holdings, Inc. (NYSE:ZMH). Prior responsibilities included management of Zimmer's European research activities. Janet has a Ph.D. in Mechanical Engineering from the University of Texas and a bachelors degree from Wellesley College.

  • Default avatar
    Art O'Dea
    VP Legal and Regulatory Affairs

    Mr. O'Dea served as VP of Intellectual Property for GEO2 Technologies, where he built the patent portfolio relating to the CLM technology. Prior to GEO2, Art was Patent Counsel for Cognex Corporation. Art has a BSME from the University of Vermont, an MS-CIM from BYU, and a JD from the Massachusetts School of Law. He is a member of the Massachusetts Bar and a registered Patent Attorney with the United States Patent and Trademark Office.


  • Default avatar
    Jeffrey D. Solomon, CPA, CVA, Katz, Nannis & Solomon, PC

Previous Investors

  • Default avatar
    Jacobs Investment Company
    Default avatar
    LTS Capital Partners
    Default avatar
    Envoi Venture Partners